Entrada Therapeutics, Inc.

TRDA · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.5B · 152 employees
81
SEC Filings
$5.06
Close 2026-11-04
152
Employees

Business Summary

Entrada Therapeutics is a clinical-stage biopharmaceutical company developing genetic medicines for neuromuscular and inherited retinal diseases using its proprietary EEV (Endosomal Escape Vehicle) platform. The company advances EEV-PMO oligonucleotide therapeutics that promote exon skipping in Duchenne muscular dystrophy (ENTR-601-44, ENTR-601-45, ENTR-601-50, ENTR-601-51), a DM1 program (VX-670) partnered with Vertex, and ocular oligonucleotide candidates (ENTR-801) for Usher syndrome type 2A. The platform uses small cyclic peptides to enable intracellular delivery of therapeutics that engage previously inaccessible targets.

Latest Stock Quote

TRDA 2026-11-04 $5.06 O:$4.83 H:$5.125 L:$4.605 Vol:0.5M VWAP:$4.964
origin leaf: null

Next Earnings

expected 2027-01-13

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001689375-26-000011EDGAR111K words
2025-02-272024-12-310001689375-25-000011EDGAR111K words
2024-03-132023-12-310001689375-24-000016EDGAR118K words
2023-03-062022-12-310001689375-23-000019EDGAR113K words
2022-03-152021-12-310001558370-22-003614EDGAR112K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-11-052026-09-300001689375-26-000064EDGAR76K words
2026-08-052026-06-300001689375-26-000054EDGAR76K words
2025-11-062025-09-300001689375-25-000050EDGAR75K words
2025-08-062025-06-300001689375-25-000043EDGAR75K words
2025-05-082025-03-310001689375-25-000024EDGAR73K words
2024-11-052024-09-300001689375-24-000063EDGAR75K words
2024-08-132024-06-300001689375-24-000047EDGAR75K words
2024-05-072024-03-310001689375-24-000027EDGAR72K words
2023-11-072023-09-300001689375-23-000074EDGAR78K words
2023-08-082023-06-300001689375-23-000055EDGAR76K words
2023-05-102023-03-310001689375-23-000039EDGAR75K words
2022-11-072022-09-300001689375-22-000045EDGAR73K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-11-050001689375-26-000063EDGAR3K words
2026-10-140001689375-26-000057EDGAR2K words
2026-08-050001689375-26-000052EDGAR3K words
2026-02-260001689375-26-000009EDGAR3K words
2026-01-080001689375-26-000003EDGAR2K words
2025-11-060001689375-25-000049EDGAR2K words
2025-08-060001689375-25-000041EDGAR2K words
2025-06-110001104659-25-058536EDGAR1K words
2025-06-030001689375-25-000027EDGAR1K words
2025-05-080001689375-25-000022EDGAR2K words

81 total filings indexed. 54 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

duchenne-muscular-dystrophy-(dmd) myotonic-dystrophy-type-1-(dm1) inherited-retinal-diseases-(usher-syndrome-type-2a) rare-pediatric-diseases united-states european-union united-kingdom eev-(endosomal-escape-vehicle)-peptide-platform phosphorodiamidate-morpholino-oligomer-(pmo)-conjugates oligonucleotide-based-exon-skipping-therapeutics organelle-targeting-moieties

Company Identity

CIK0001689375
TickerTRDA
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.entradatx.com
Listed2021-10-29

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: fa901a1c6fb06261c06ba8d6c9b9463426a7dcd80ea1fe40b5e2d431022b9753
parent: 01bee7cc7268f440868e68bb3b399d145d19b3659dcd110720be7437ee3c052e
content hash: c55b3a2e3c6215beccfd0a732942a0efd0cd818523391637ebbc41b5cb370648
signed: 2026-11-16T19:05:12.221Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up TRDA using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on TRDA, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/TRDA (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.